PTC Therapeutics | PTCT - Assets



PTC Therapeutics reported $2.63B in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
Acadia Pharmaceuticals USD 1.23B 93.19M Jun/2025
Alnylam Pharmaceuticals USD 4.57B 352.21M Jun/2025
Amgen USD 87.9B 1.47B Jun/2025
Biogen USD 28.33B 297.1M Jun/2025
BioMarin Pharmaceutical USD 7.46B 309.33M Jun/2025
Cytokinetics USD 1.23B 38.42M Jun/2025
Daiichi Sankyo JPY 3.46T 3.5B Jun/2025
Gilead Sciences USD 55.72B 713M Jun/2025
Incyte USD 5.82B 71.99M Jun/2025
Ionis Pharmaceuticals USD 2.99B 172.18M Jun/2025
Ironwood Pharmaceuticals USD 351.3M 38.22M Dec/2024
Novartis USD 104.4B 4.45B Jun/2025
Pfizer USD 206.1B 1.93B Jun/2025
PTC Therapeutics USD 2.63B 21.23M Jun/2025
Roche Holding CHF 101.8B 6.02B Dec/2024
Sarepta Therapeutics USD 3.68B 214.43M Jun/2025
TG Therapeutics USD 702.61M 45.92M Jun/2025
Ultragenyx Pharmaceutical USD 1.31B 5.66M Jun/2025
Vertex Pharmaceuticals USD 24.04B 1.16B Jun/2025
Xencor USD 879.42M 25.26M Jun/2025